A multi-stage transcriptomic resource of Artemisitene (ATT) for enhancing liver organoid functionality and treating metabolic liver disease.

Accession: GSE317876
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, GPL24676
Organism: human
Samples: 21
Size (indexed): 2.7 MB (2868081 bytes)
Downloaded bytes: 2.7 MB (2868081 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE317876_FFA_rawcounts.xls.gz1.0 MBc9e817c15885ce4b…
GSE317876_HBorg-rawcounts.xls.gz830.1 KBa856a1cf067cd405…
GSE317876_PHep-rawcounts.xls.gz901.9 KBeabf900a8320b417…

Index note: 3 suppl file(s); GSE317876_FFA_rawcounts.xls.gz

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T16:51:40Z.

About this dataset

This Expression profiling by high throughput sequencing, GPL24676 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 21 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.